| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86e3f9618a91993ccbe28b6938a6de99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ad0326688e21e36026b427d539d69f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_207df7a866be274cd89ea723e9efaf37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec36465b626501d67e3e6ff8bee5dd1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b90c6e29be8f2c7dbf4040ad421acd4f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09 |
| filingDate |
2004-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_099038f879c48a5facf7d6e09ac861a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad77d66ec8306f26692c881a2fb490a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d911d6ce0769c66ea9ba9d16ec787695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d2b2355c7b92c844098dbfb5c8c2a9f |
| publicationDate |
2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005050215-A8 |
| titleOfInvention |
Selection of lactic acid bacteria enhancing the immune response against streptococcus pneumoniae |
| abstract |
A method of selection of lactic acid bacteria for providing a method of protecting humans against Streptococcus pneumoniae infections by selecting a lactic acid bacterial strain (LAB) naturally carrying genes coding for proteins similar to the PspC, choline binding protein of S. pneumoniae so that the selected LAB can be used in various products for oral and nasal administration to humans as immune enhancers against S. pneumoniae, and products containing specifically selected LAB that naturally carry genes coding for proteins similar to PcpC binding protein of S. pneumoniae as oral and nasal immune enhancers for humans. |
| priorityDate |
2003-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |